SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

UBS Maintains Buy Rating on Ralph Lauren

UBS maintained its Buy rating on Ralph Lauren.

RL
SquawkNews Desk

Related stories

China Resources Microelectronics Q3 Net Profit Rises 36.45% Y/Y M impact | EQUITY | Oct 29, 2026, 12:52 PM UTC Kymera Therapeutics Q3 Net Loss Widens Kymera Therapeutics reported a wider net loss for the third quarter. M impact | EQUITY | Oct 29, 2026, 12:52 PM UTC Nolato Publishes Transcript of Q3 2026 Results Presentation M impact | EQUITY | Oct 29, 2026, 12:51 PM UTC Baiyin Nonferrous Group Reports Q3 Net Profit of 636.9 Million Yuan M impact | EQUITY | Oct 29, 2026, 12:51 PM UTC Zensar Technologies Shares Jump 8.17%, Rise 25% in a Month Zensar Technologies shares rose nearly 8.17% Thursday, extending their gains to around 25% over the past month. M impact | EQUITY | Oct 29, 2026, 12:51 PM UTC BioMarin Licenses Fabry Disease Therapy From GC Biopharma and Hanmi Pharm BioMarin entered an exclusive license for a Fabry disease therapy from GC Biopharma and Hanmi Pharm. M impact | EQUITY | Oct 29, 2026, 12:50 PM UTC